Glenmark Pharmaceuticals Ltd.
|
Nine Months RESULTS
|
|
You can view the
Nine Months Results
for the last 5 years.
Market Cap. (Rs.)
|
29416.70 Cr.
|
P/BV
|
3.11
|
Book Value (Rs.)
|
335.73
|
52 Week High/Low (Rs.)
|
1098/581
|
FV/ML
|
1/1
|
P/E(X)
|
98.97
|
Bookclosure
|
29/09/2023
|
EPS (Rs.)
|
10.53
|
Div Yield (%)
|
0.24
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 8750.15 | 9616.40 | 9213.05 | 8084.03 | 7873.48 |
Other Operating Income | 0.00 | 0.00 | 72.71 | 0.00 | 0.00 |
Total Income From Operations | 8750.15 | 9616.40 | 9285.76 | 8084.03 | 7873.48 |
| | | | | |
EXPENDITURE | | | | | |
Consumption of Raw Materials | 2403.51 | 2717.00 | 2488.82 | 2351.93 | 1947.47 |
Purchase of Traded Goods | 1240.36 | 1037.87 | 879.26 | 572.70 | 848.65 |
Increase/Decrease in Stocks | -226.04 | -410.02 | -13.67 | -164.18 | -73.54 |
Employees Cost | 2167.19 | 2123.38 | 1869.74 | 1806.50 | 1730.54 |
Depreciation | 430.57 | 464.74 | 355.19 | 332.49 | 290.89 |
Other Expenses | 2474.13 | 2474.77 | 2204.70 | 1956.13 | 2187.96 |
Total Expenses | 8489.73 | 8407.73 | 7784.05 | 6855.56 | 6931.98 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 260.42 | 1208.67 | 1501.71 | 1228.47 | 941.50 |
Other Income | 66.83 | 357.00 | 59.47 | 41.72 | 115.46 |
P/L Before Interest, Excpt. Items & Tax | 327.25 | 1565.67 | 1561.18 | 1270.19 | 1056.96 |
Interest | 367.41 | 240.33 | 211.24 | 269.78 | 278.84 |
P/L Before Exceptional Items & Tax | -40.16 | 1325.34 | 1349.94 | 1000.41 | 778.12 |
Exceptional Items | -454.17 | 33.88 | -178.38 | 44.55 | 0.00 |
P/L Before Tax | -494.33 | 1359.22 | 1171.56 | 1044.96 | 778.12 |
Tax | 97.87 | 578.68 | 350.47 | 308.74 | 222.46 |
P/L After Tax from Ordinary Activities | -592.20 | 780.54 | 821.08 | 736.21 | 555.66 |
Extra Ordinary Item | 372.95 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Profit/Loss For the Period | -219.25 | 780.54 | 821.08 | 736.21 | 555.66 |
Net P/L After Minority Interest & Share Of Associates | -219.25 | 780.54 | 821.08 | 736.21 | 555.66 |
| | | | | |
Equity Share Capital | 28.22 | 28.22 | 28.22 | 28.22 | 28.22 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | -10.04 | 25.71 | 27.86 | 26.09 | 19.69 |
Diluted EPS (Rs.) | -10.04 | 25.71 | 27.86 | 26.09 | 19.69 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | -10.04 | 25.71 | 27.86 | 26.09 | 19.69 |
Diluted EPS (Rs.) | -10.04 | 25.71 | 27.86 | 26.09 | 19.69 |
| | | | | |
PBITOE Margin (%) | 2.97 | 12.56 | 16.17 | 15.19 | 11.95 |
PBTE Margin (%) | -0.45 | 13.78 | 14.53 | 12.37 | 9.88 |
PBT Margin (%) | -5.64 | 14.13 | 12.61 | 12.92 | 9.88 |
PAT Margin (%) | -2.50 | 8.11 | 8.84 | 9.10 | 7.05 |
PAT After MI And SOA Margin (%) | -2.50 | 8.11 | 8.84 | 9.10 | 7.05 |